Syntarga BV
Toernooiveld 1
Nijmegen
6525 ED
Tel: 31-24-3652878
Website: http://www.syntarga.com/
Email: info@syntarga.com
9 articles about Syntarga BV
-
Synthon Acquires Syntarga BV and its Antibody-Drug Conjugate Technology
6/23/2011
-
Aglaia Oncology Announces Sale of Portfolio Company Syntarga BV
6/23/2011
-
Syntarga BV Announces New Antibody-Drug Conjugate Collaborations
4/7/2011
-
Syntarga BV Announces Additional Antibody-Drug Conjugate Collaborations
6/1/2010
-
Syntarga BV Announces Two Antibody-Drug Conjugate Collaborations with Top-tier Biopharmaceutical Companies
3/4/2010
-
Syntarga BV Announces Patent Grant for SpaceLink Technology for Antibody-Drug Conjugation
7/16/2009
-
Syntarga BV Demonstrates In Vivo Proof of Concept for its Antibody-Drug Conjugate Technology
1/8/2009
-
Syntarga BV Appoints Antibody-Drug Conjugate expert Dr. Nitin Damle as Advisor
7/21/2008
-
Syntarga BV Licenses Potent Cell-Killing Drugs From The University Of Göttingen, Germany
3/15/2006